You might not think of diabetes when you think of muscle function. But a common diabetes drug that regulates blood sugar can also prevent muscle atrophy and muscular fibrosis -- which can help the ...
As people age, muscles naturally lose mass and strength, a condition known as sarcopenia. The decline can make everyday ...
A commonly prescribed drug for diabetes, metformin, has a new side hustle. Besides helping to manage blood sugar in Type 2 diabetes, metformin can also fight off a type of cell that builds up in the ...
Muscle atrophy is a prevalent condition in today's societies, but many of the roles that mitochondria play in the process remain unclear. In a recent study, researchers investigated how muscle atrophy ...
Loss of muscle mass (muscle atrophy) can be a result of aging or lifestyle habits, like being inactive or eating a poor diet. Muscle loss can also point to hormone abnormalities or underlying health ...
NEW ORLEANS — Medications in development would preserve muscle mass and augment fat loss when used in combination with glucagon-like peptide 1 (GLP-1) receptor agonists taken for weight loss. Several ...
Muscle-on-chip systems are three-dimensional human muscle cell bundles cultured on collagen scaffolds. A Stanford University research team sent some of these systems to the International Space Station ...
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. So most recently, there has been the ...
Panelists discuss how the current spinal muscular atrophy (SMA) treatment landscape includes 3 options: gene therapy (onasemnogene abeparvovec [Zolgensma]) for younger patients and 2 splice modifiers ...
Add Yahoo as a preferred source to see more of our stories on Google. Ever skip the gym for a few days… and suddenly realize it's been three weeks? Whether it was work, travel, injury, or life just ...
A small new study found that women who ate less protein tended to lose the most lean mass while taking semaglutide. Simon Spichak finished his MSc at University College Cork, where he studied the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results